Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 2,604,000 | 2,234,000 | 1,551,346 | 1,134,114 | 783,431 |
| Cost of Goods | 233,100 | 174,000 | 177,556 | 72,837 | 93,140 |
| Gross Profit | 2,370,900 | 2,060,000 | 1,373,790 | 1,061,277 | 690,291 |
| Operating Expenses | 1,834,300 | 1,191,000 | 846,336 | 657,776 | 459,605 |
| Operating Income | 536,700 | 869,000 | 528,010 | 404,338 | 230,826 |
| Interest Expense | 47,800 | 3,000 | 4,112 | 7,402 | 788 |
| Other Income | 9,200 | 6,000 | 2,371 | 630 | -370 |
| Pre-tax Income | 498,100 | 872,000 | 526,269 | 397,566 | 229,668 |
| Income Tax | 353,700 | 215,000 | 273,374 | 142,744 | 54,353 |
| Net Income Continuous | 144,400 | 657,000 | 252,895 | 254,822 | 175,315 |
| Net Income | $144,400 | $657,000 | $252,895 | $254,822 | $175,315 |
| EPS Basic Total Ops | 0.68 | 3.32 | 1.29 | 1.34 | 0.96 |
| EPS Basic Continuous Ops | 0.68 | 3.32 | 1.29 | 1.34 | 0.96 |
| EPS Diluted Total Ops | 0.67 | 3.26 | 1.27 | 1.28 | 0.91 |
| EPS Diluted Continuous Ops | 0.67 | 3.25 | 1.27 | 1.28 | 0.91 |
| EPS Diluted Before Non-Recurring Items | 4.55 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $703,300 | $928,000 | $593,459 | $454,525 | $248,418 |